Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125257351 | 12525735 | 1 | I | 20160623 | 20160705 | 20160705 | EXP | US-ZYDUS-011487 | ZYDUS PHARM | EIKELENBOOM-SCHIEVELD SJM, LUCIRE Y, FOGLEMAN JC. THE RELEVANCE OF CYTOCHROME P450 POLYMORPHISM IN FORENSIC MEDICINE AND AKATHISIA-RELATED VIOLENCE AND SUICIDE. J-FORENS-LEGAL-MED 2016; 4165-71. | 33.00 | YR | F | Y | 0.00000 | 20160705 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125257351 | 12525735 | 1 | PS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | UNNOWN | 77106 | ||||||||||
| 125257351 | 12525735 | 2 | SS | VENLAFAXINE/VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | UNKNOWN | 77653 | 150 | MG | ||||||||
| 125257351 | 12525735 | 3 | I | TEMAZEPAM. | TEMAZEPAM | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 125257351 | 12525735 | 4 | I | QUETIAPINE/QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 125257351 | 12525735 | 5 | SS | VENLAFAXINE/VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | UNKNOWN | 77653 | 75 | MG | ||||||||
| 125257351 | 12525735 | 6 | SS | VENLAFAXINE/VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | U | UNKNOWN | 77653 | |||||||||
| 125257351 | 12525735 | 7 | C | DESVENLAFAXINE. | DESVENLAFAXINE | 1 | Unknown | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125257351 | 12525735 | 1 | Anxiety |
| 125257351 | 12525735 | 2 | Product used for unknown indication |
| 125257351 | 12525735 | 3 | Anxiety |
| 125257351 | 12525735 | 4 | Insomnia |
| 125257351 | 12525735 | 5 | Product used for unknown indication |
| 125257351 | 12525735 | 6 | Product used for unknown indication |
| 125257351 | 12525735 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125257351 | 12525735 | OT |
| 125257351 | 12525735 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125257351 | 12525735 | Abnormal behaviour | |
| 125257351 | 12525735 | Delusion | |
| 125257351 | 12525735 | Drug interaction | |
| 125257351 | 12525735 | Extra dose administered | |
| 125257351 | 12525735 | Fatigue | |
| 125257351 | 12525735 | Homicide | |
| 125257351 | 12525735 | Inappropriate schedule of drug administration | |
| 125257351 | 12525735 | Mood swings | |
| 125257351 | 12525735 | Panic attack | |
| 125257351 | 12525735 | Physical assault | |
| 125257351 | 12525735 | Thinking abnormal | |
| 125257351 | 12525735 | Toxicity to various agents | |
| 125257351 | 12525735 | Treatment noncompliance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |